skip to content »

Lester and Sue Smith Breast Center

Houston, Texas

The Lester and Sue Smith Breast Center's mission is to improve prevention, diagnosis and treatment of breast disease.
Lester & Sue Smith Breast Center
not shown on screen

Xiaosong Wang, M.D., Ph.D. - Biography

Assistant Professor

Lester & Sue SMith Breast Center & Dan L. Duncan Cancer Center

Section of Hematology/Oncology, Department of Medicine

Department of Molecular and Cellular Biology

Xiaosong Wang, M.D., Ph.D.Phone: 713-798-1624
Fax: 713-798-1642


Education and Training:

M.D.: First hospital of China Medical University, Shenyang, China

Ph.D.: Institute of Urology & Department of Immunology, Peking University Health Science Center, Beijing, China

Postdoctoral Training:
Michigan Center for Translational Pathology & National Center for Integrative bioinformatics, University of Michigan, Ann Arbor

Wang lab Website:

Research Interests:

The advancements of high-throughput transcriptomic, genomic and deep sequencing technologies have generated a flood of data in the public domain and private warehouse. However, the laboratory discoveries based on analysis of these data have met with limited success. Innovative computational technologies that can directly address the biological and clinical problems in cancer are of high demand. The mission of our group is to apply a multiple disciplinary approach inclusive of bioinformatics, genomics, molecular and cell biology, and translational studies to detect driving genetic aberrations and qualify appropriate breast cancer targets on the basis of the state-of-art high-throughput technologies.

Our current research focus is to discover and characterize novel therapeutic targets and predictive biomarkers in breast cancer. By interrogating multidimensional genomic datasets with a drug-target database and a “concept signature” analysis we developed to reveal oncogenes (Nature Biotechnology, 2009), we nominated several oncogenes deregulated by genetic or epigenetic events as potential therapeutic targets and/or predictive biomarkers in breast cancer. Four candidate targets have been validated by our preliminary experimental and clinical data. We are investigating the clinical relevance and biological function of these targets, as well as their role in breast cancer therapeutic resistance. Part of this project has been funded by the DOD Breast Cancer Idea Award, and the Susan G. Komen for the Cure Postdoc Fellowship. We expect that our new discoveries will yield novel insights into recurring genetic and epigenetic abnormalities leading to breast cancer, and establish robust targets for effective and personalized therapies.

Contact Information

Baylor College of Medicine
One Baylor Plaza
Alkek Research Building N1110.03
Mail Stop BCM600
Houston, TX, 77030
Phone: 713-798-1624
Fax: 713-798-1642

E-mail this page to a friend